Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-02-28 @ 10:52 PM
Study NCT ID:
NCT01195532
Status:
UNKNOWN
Last Update Posted:
2010-09-06
First Post:
2010-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
Sponsor:
Taipei Medical University WanFang Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
A29GLI60-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Hsingjin E. Liu, MD, PhD.
Old Organization:
Taipei Medical University WanFang Hospital